Sir,
I thank Shimizu et al. for their interest in our paper entitled “Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials” [1]. We are thankful to the authors for their valuable re-analysis of our meta-analysis and bringing forth the additional advantage of diarrhea prevention in ventilated patients by the use of probiotics. We agree that we missed inclusion of their valuable study entitled “Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial” [2] while performing the forest plot analysis of the incidence of diarrhea in ventilated ICU patients. Both the reviewers again analyzed the data and found that as the authors had used the word “enteritis” and “loose stools” in their paper in place of “diarrhea” the study was missed in the analysis.
Most previous meta-analysis such as by Su et al. and Johnstone et al. [3, 4]have missed this important finding. A recently published randomized control study by Johnstone et al. [5] showed that there was no significant difference in diarrhea between patients in the probiotic group vs placebo group. Thus, we re-assessed the meta-analysis after adding this study also to our meta-analysis (as shown in Fig. 1). The effect was seen on a total of 3176 patients (1582 probiotic group vs 1594 placebo group). Moderate heterogeneity (OR 0.63, CI 0.38, 1.04; P = 0.07; I2 = 65%) was seen between the studies. After adding this study, it can be seen that the trend favors probiotics in reducing the risk of diarrhea in ventilated patients though the effect is not statistically significant.
Fig. 1.
A forest plot of the incidence of diarrhea
The use of probiotics has been well known to be associated with the reduction of C. difficile-associated diarrhea as supported by Goldenberg et al. [6] and Gokalani et al. [7]. This additional knowledge of the role of probiotics in prevention of diarrhea in ventilated patients is valuable and would encourage most clinicians in the use of probiotics in all ventilated ICU patients.
Acknowledgements
None.
Authors' contributions
All authors read and approved the final manuscript.
Funding
Not applicable.
Availability of data and materials
Available with the corresponding author.
Declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
There are no competing interests to be declared.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Batra P, Soni KD, Mathur P. Efficacy of probiotics in the prevention of VAP in critically ill ICU patients: an updated systematic review and meta-analysis of randomized control trials. J Intensive Care. 2020;8:81. doi: 10.1186/s40560-020-00487-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Shimizu K, Yamada T, Ogura H, Mohri T, Kiguchi T, Fujimi S, et al. Synbiotics modulate gut microbiota and reduce enteritis and ventilator-associated pneumonia in patients with sepsis: a randomized controlled trial. Crit Care Lond Engl. 2018;22(1):239. doi: 10.1186/s13054-018-2167-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Su M, Jia Y, Li Y, Zhou D, Jia J. Probiotics for the prevention of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Respir Care. 2020;65(5):673–685. doi: 10.4187/respcare.07097. [DOI] [PubMed] [Google Scholar]
- 4.Johnstone J, Heels-Ansdell D, Thabane L, Meade M, Marshall J, Lauzier F, et al. Evaluating probiotics for the prevention of ventilator-associated pneumonia: a randomised placebo-controlled multicentre trial protocol and statistical analysis plan for PROSPECT. BMJ Open. 2019;9(6):e025228. doi: 10.1136/bmjopen-2018-025228. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Johnstone J, Meade M, Lauzier F, Marshall J, Duan E, Dionne J, et al. Effect of probiotics on incident ventilator-associated pneumonia in critically Ill patients: a randomized clinical trial. JAMA. 2021;326(11):1024–1033. doi: 10.1001/jama.2021.13355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Goldenberg JZ, Yap C, Lytvyn L, Lo CK-F, Beardsley J, Mertz D, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017 doi: 10.1002/14651858.CD006095.pub4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Rutul .A .Gokalani D. Prevention of Antibiotic-Associated Diarrhea: Role of Probiotics [Internet]. 2021 https://medicaldialogues.in/medicine/perspective/prevention-of-antibiotic-associated-diarrhea-role-of-probiotics-81698. Accessed 7 Sep 2021.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Available with the corresponding author.